"If this drug treatment is not effective, then it will lose money."

The first full oral direct anti-hepatitis C virus combination treatment test "pay for efficacy"

According to news from Health Point, on August 15th, China’s first “pay-as-you-go” policy issued by Huatai Property Insurance was officially born. The policy will take antiviral treatment drugs during the insurance period (Bai Lize + Suvi) The treatment effect of patients with hepatitis C was underwritten. After completing a course of treatment for 24 weeks and following 12 weeks of follow-up, if the treatment effect is not achieved, the insurance company will compensate the insured for part of the purchase cost. The compensation amount is 30000 yuan.

In April of this year, Bristol-Myers Squibb launched Bai Lize (Daratavir) and Synaptic (Ashuvir) as the first all-oral direct anti-hepatitis virus combination treatment program approved by the CFDA in China for treatment. Adult gene type 1b chronic hepatitis C (non-cirrhosis or compensated cirrhosis). In addition, Bentley is also approved for use in combination with other drugs such as sophos-blister* for the treatment of adult pan-genotype (ie, genotype 1-6) chronic hepatitis C virus infection, which is also the only Chinese hepatitis C virus. The Guide to Prevention and Control is recommended for a total oral combination therapy for the treatment of pan-genotypes.

According to the clinical study results of patients admitted to mainland China, the cure rate of the combination of Bailixer and Suweipu for patients with type 1b chronic hepatitis C is 91%-99%, and the safety and tolerability are good 2-3.

It is understood that Bilzer is the first NS5A inhibitor to target the NS5A protein and directly destroy its normal function. Super-Vip is an NS3 protease inhibitor that binds to the hepatitis C virus NS3 protein, thereby inhibiting its activity. The action of the two drugs against the two parts of the hepatitis C virus can inhibit the replication of the hepatitis C virus in multiple links, thereby making "the enemy completely annihilated."

According to the statistics of health points, only three months after obtaining CFDA approval, Bristol-Myers Squibb launched the Bailixer joint speed speed in the Chinese market in early July, including 121 hospitals and 548 pharmacies across the country. DTP pharmacy for direct sales channels of patients nationwide.

However, the combined treatment of “Bai Li Ze + Su Wei Pu” has not entered the medical insurance, and it is completely necessary for the patient to pay at his own expense. According to estimates, the cost of a treatment for this treatment plan is between 55,000 and 60,000 yuan.

Rapier Loom

We are a supplier of high-speed rapier looms and flexible rapier looms. The company specializes in selling second-hand rapier looms and economical rapier looms. Chinese second-hand rapier looms look for Tianchi.

Second-Hand Rapier Loom,High-Speed Rapier Loom,Flexible Rapier Loom,Rapier Loom

Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejts.com